Mark Rolfe

Corporate Officer/Principal at BRISTOL-MYERS SQUIBB COMPANY

Health Technology

Consumer Services

Retail Trade

Profile

Mark Rolfe is a professional with a current job as Senior Vice President at Bristol Myers Squibb Co. He previously worked at GPC Biotech, Inc. as Director-Molecular Biology, Millennium Pharmaceuticals, Inc. as Vice President-Oncology Discovery Group, Abbott Biotherapeutics Corp.
as Senior VP, Chief Scientific & Medical Officer, UCB Pharma, Inc. as Principal Scientist-Oncology, CytomX Therapeutics Holdings LLC as Chief Scientific Officer, and Cleave Therapeutics, Inc. as President & Chief Scientific Officer.
He received his undergraduate and graduate degrees from the University of Oxford and his doctorate from the University of London.

Mark Rolfe active positions

Companies	Position	Start
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	2019-10-31

All active positions of Mark Rolfe

Former positions of Mark Rolfe

Companies	Position	End
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Corporate Officer/Principal	1998-12-31
UCB Pharma, Inc. UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA.	Corporate Officer/Principal	-
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-
Abbott Biotherapeutics Corp. Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.	Chief Tech/Sci/R&D Officer	-
Cleave Therapeutics, Inc. Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA.	President	-

See the detail of Mark Rolfe's experience

Training of Mark Rolfe

University of Oxford	Graduate Degree
University of London	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Rolfe's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BRISTOL-MYERS SQUIBB COMPANY	Health Technology

Private companies	6
CytomX Therapeutics Holdings LLC CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA.	Health Technology
Cleave Therapeutics, Inc. Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA.	Health Technology
Abbott Biotherapeutics Corp. Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA.	Health Technology
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Health Technology
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Retail Trade
UCB Pharma, Inc. UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA.	Commercial Services

See company connections